Purchase Order 75N94022P00567
- Not listed
- This is a $13,400 firm fixed-price purchase order contract awarded by the National Eye Institute, a civilian agency within the National Institutes of Health, to Novogene Corp Inc., a minority-owned small business. The contract is for cell handling and sequencing services, with a period of performance through September 30, 2024. Novogene is a genomics services provider that specializes in next-generation DNA and RNA sequencing, bioinformatics, and research support for federal agencies across...
- This $20,850 firm fixed-price purchase order was awarded to Novogene Corp Inc., a minority-owned small business, by the National Institute of Allergy and Infectious Diseases (NIAID) on September 12, 2024. The contract is for RNA sequencing services to support NIAID's biomedical research efforts, with a completion date of September 11, 2025. Novogene is an experienced provider of genomic sequencing and bioinformatics services to various federal agencies, holding multiple prime contracts and...
- This is a firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Novogene Corp Inc., a minority-owned small business. The contract, valued at $13,748.40, is for RNA sample quality control services. No set-aside was used. Novogene is a provider of next-generation sequencing and bioinformatics services, and has established a significant relationship with federal agencies through numerous prime contract and...
- This federal contract award is for $143,850.00 to Novogene Corp Inc., a minority-owned small business, by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse. The contract is a firm fixed price purchase order for genomic sequencing and bioinformatics services to support biomedical research. Novogene has previously received over 100 prime contracts from federal agencies including the NIH, Department of Veterans Affairs, Department of...
- This is a firm fixed-price purchase order awarded by the Northeast Area of the U.S. federal agency to Novogene Corp Inc., a minority-owned small business, for DNA sequencing services. The contract has a ceiling value of $84,050.00 and a performance period ending on April 30, 2018. Novogene is a provider of next-generation sequencing technologies, including whole genome, exome, transcriptome, and metagenomic sequencing, and has delivered services to various federal agencies such as the National...
- This federal contract award to Novogene Corp Inc., a minority-owned small business, is for DNA library preparation and amplicon sequencing services. The $11,250.00 firm fixed price purchase order was awarded by the Northeast Area division of the U.S. Civilian agency on July 24, 2017, with a completion date of October 31, 2017. Novogene is an established provider of next-generation sequencing, bioinformatics, and genomic analysis services to various federal agencies, including the National...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to Novogene Corp Inc., a minority-owned small business, for RNA sequencing analysis services. The $10,880 contract has a completion date of December 11, 2024 and was not set aside. Novogene is a provider of genomic sequencing and bioinformatics services, supporting various federal agencies' biomedical, agricultural, environmental, and basic research efforts. This award...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Aging, a civilian federal agency, to Novogene Corporation Inc., a minority-owned small business based in Sacramento, California. The contract is for $21,800 and covers laboratory and testing services, specifically strand-specific mRNA sequencing and bioinformatics analysis, with a period of performance through March 31, 2026. Novogene has an established track record of providing advanced genomic sequencing...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $24,577.00 firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for DNA and RNA sequencing services. This contract is set aside for small businesses. Novogene is a provider of next-generation sequencing technologies that has delivered services to support various federal agencies' biomedical, agricultural, environmental, and basic...
- This is a firm fixed-price purchase order awarded by the Plains Area division of a civilian federal agency to Novogene Corporation Inc., a minority-owned small business. The contract, valued at $62,346.90, is for genomic sequencing services and covers the period through December 31, 2024. Novogene is a provider of next-generation sequencing technologies, including whole genome, exome, transcriptome, and metagenomic sequencing, and has delivered these services to various government agencies...
This firm fixed-price purchase order was awarded to Novogene Corporation Inc., a minority-owned small business, by the National Institute of Child Health and Human Development for gene expression profiles (Alirocumab neuroinflammation apoptosis) in the amount of $54,080.00. The award is not associated with a set-aside and is based on a competitive solicitation for providing and analyzing gene expression and complete DNA library preparation, NovaSeq PSK9 (sequencing), and customized analysis. Novogene Corporation Inc. is a provider of genomic sequencing and bioinformatics services to various federal agencies, supporting research across disciplines such as biomedical, agricultural, environmental, and basic sciences. The company has established a strong track record of contract awards from agencies like the National Institutes of Health, Department of Veterans Affairs, and the U.S. Geological Survey, delivering critical DNA and RNA sequencing, library preparation, and data analysis services to advance the government's scientific initiatives.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
FBO For mRNA Sequencing | 75N94022Q00155 | Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development | Solicitation 1/1 | 7/21/22, 2:41 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | $0 | 6/25/24 | |
| Not listed | Not listed | $54.1k | 7/28/22 |